SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the company begins testing driverless robotaxis in Austin, spurring optimism about future revenue streams. The community is discussing the potential for Tesla's AI and full self-driving technology to revolutionize personal transportation and logistics, while some express skepticism about valuation. Bullish sentiment prevails, with some traders anticipating a continued rally towards $500, while others believe the stock is overvalued and due for a correction.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

NVTS is trending as the community discusses its high short interest and potential for a short squeeze, with many citing positive news and partnerships as catalysts. Despite recent market volatility and overnight drops, some investors see it as a buying opportunity, while others express concerns about profitability and competition. Discussions also include speculation about a potential acquisition and the impact of Navitas' technology on AI data centers.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending due to its low float and AI/robotics association, leading to discussions about potential for fast gains. Community chatter highlights momentum trading strategies, cautioning against relying on fundamentals given the stock's meme-like behavior. Some traders are drawing comparisons to previous high-flying low floaters, while others discuss short squeeze potential.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending as investors grapple with a recent price decline, despite the company's exposure to power, GPUs and AI. Community discussion revolves around whether this dip presents a buying opportunity, with some citing the company's long-term potential in data centers amid the growing AI infrastructure demand, while others point to concerns about cash flow and market volatility. Some traders are closely watching Bitcoin's movements as a potential indicator for IREN's short-term price action.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to positive interim data from its RAD 101 brain metastases imaging agent trial, sparking significant volatility and a surge in trading volume. The community is actively discussing potential short squeezes, buyout possibilities, and the impact of an upcoming webinar, while also weighing concerns about potential dilution after a large price swing. Bullish sentiment centers on the company's strong cash position through 2026 and the potential for further gains, while bears cite concerns about overvaluation and promotional activity.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as excitement builds around its advancements in AI and autonomous driving technology, highlighted at its recent AI & Autonomy Day, with community members pointing to the potential for Rivian to emerge as a strong competitor against Tesla. Bullish sentiment is fueled by Needham's price target increase and discussion of Rivian's innovative AI chip. Some analysts are suggesting Rivian could become a leading EV player in North America, driving investor interest.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the Platform and Devices segments. The Platform segment includes digital advertising and related services including the demand-side platform and content distribution services such as subscription and transaction revenue shares, media and entertainment promotional spending, the sale of premium subscriptions, and the sale of branded channel buttons on remote controls. The Devices segment is involved in the sale of streaming players, audio products, smart home products, and accessories that are sold through retailers and distributors, as well as directly to customers through the company’s website. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku ($ROKU) is trending amid analyst upgrades and anticipation for earnings, with the community discussing the company's potential for platform revenue growth and ad monetization. Bullish sentiment is fueled by expectations for a strong report, though some traders are cautious, citing historical patterns of post-earnings dips. The stock's ability to hold above key resistance levels is also a focal point, reflecting broader debates around valuation and market positioning.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending as investors await topline results from its REZOLVE-AA Phase 2b study in Alopecia Areata, expected soon, with a conference call scheduled to discuss the data. The community speculates on the potential outcome, drawing comparisons to previous data releases and considering the implications for a potential buyout. Some traders are also monitoring a court case with Lilly, anticipating a possible settlement.

Pentair plc engages in the provision of water solutions for residential, commercial, industrial, infrastructure, and agricultural applications. It operates through the following segments: Flow, Water Solutions, and Pool. The Flow segment designs, manufactures, and sells various fluid treatment and pump products and systems, including pressure vessels, gas recovery solutions, membrane bioreactors, wastewater reuse systems and advanced membrane filtration, separation systems, water disposal pumps, water supply pumps, fluid transfer pumps, turbine pumps, solid handling pumps, and agricultural spray nozzles, while serving the global residential, commercial, and industrial markets. The Water Solutions segment covers commercial and residential water treatment products and systems, including pressure tanks, control valves, activated carbon products, commercial ice machines, conventional filtration products, and point-of-entry and point-of-use water treatment systems. The Pool segment refers to a line of energy-efficient residential and commercial pool equipment and accessories, including pumps, filters, heaters, lights, automatic controls, automatic cleaners, maintenance equipment, and pool accessories. The company was founded by Murray J. Harpole, Vern Stone, Vincent Follmer, Leroy Nelson, and Gary Ostrand on August 31, 1966 and is headquartered in London, the United Kingdom.

Pentair plc

Pentair ($PNR) is trending as analysts update ratings and price targets, with community members discussing potential impacts from senator Mullin's reported stock purchase. Recent reports suggest a possible sale of part of the industrial arm and the closing of the Manitowoc Ice acquisition. Investors are also following Q3 earnings estimates and guidance.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending due to a mix of analyst ratings, acquisition rumors, and reactions to its recent earnings report and raised guidance. Community discussion revolves around the stock's volatile price action and whether it represents a buying opportunity or reflects concerns about valuation and AI competition.  Investors are also closely watching for a potential stock split.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

5 Best-Performing Leveraged ETFs of Last Week

Cannabis, space, nat gas & auto led last week's leveraged ETF winners. MSOX, RKLX, KOLD, VOYX and CVNX posted outsized gains despite tech weakness.

Cannabis ETFs Soar Double-Digits on Friday: Here's Why

Cannabis ETFs explode on reform buzz. CNBS, WEED, MSOS and MJ jumped double-digits on Dec. 12, 2025 as Trump reportedly weighs reclassifying marijuana, boosting optimism.

The Zacks Analyst Blog Highlights MSOS, CNBS, WEED, MJ and YOLO

Zacks Analyst Blog highlights MSOS, CNBS, WEED, MJ, and YOLO as marijuana ETFs soar over 100% in three months on U.S. legalization hopes and investor optimism.

From Loss to Lift-Off: Marijuana ETFs Rebound on Legalization Prospects 

Marijuana ETFs, such as WEED, MSOS, and CNBS, are rebounding as hopes for rescheduling boost investor optimism. 

Top-Performing ETF Areas of August That Are Up At Least 20% 

ETFs tied to Cannabis, Asia, China, materials and bitcoin miners led August's gains in Wall Street. ETFs like WEED, KSTR, CNXT, GBUG and WGMI won in August.

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.


Tilray Brands, Inc. faces a regulatory reckoning: regain Nasdaq’s minimum bid price requirements soon or possibly get delisted from the exchange.&nbsp;The retail trading community on Stocktwits believes the cannabis and beer company will soon overcome this hurdle.Leamington, Canada-based Tilray received a non-compliance notice from Nasdaq on Tuesday after its stock failed to maintain the exchange’s $1 minimum closing bid price requirement for 30 consecutive business days.Shares of Tilray have lost more than half their value this year, as cannabis-linked stocks continue to struggle amid stalled federal legalization efforts.The company has 180 calendar days to meet Nasdaq's minimum bid price rule. Its stock must close at or above $1.00 per share for at least 10 consecutive business days before Sept. 21.If the company fails, it may transfer to the Nasdaq Capital Market for another 180-day extension — provided it meets other listing requirements and notifies Nasdaq of its plan to fix the issue, possibly through a reverse stock split.&nbsp;If Nasdaq still determines the company cannot regain compliance, its stock will face delisting.On Stocktwits, sentiment for Tilray ended on a slightly higher ‘bullish’ level on Wednesday amid a 45% jump in message volume.<figure class="image"><img style="aspect-ratio:1318/302;" src="https://news.stocktwits-cdn.com/TLRY_sentiment_and_message_volume_as_of_Macrh_26_png_785b929906.webp" alt="TLRY sentiment and message volume as of Macrh 26.png" width="1318" height="302"><figcaption>TLRY sentiment and message volume as of Macrh 26. | source: Stocktwits</figcaption></figure>One user expressed hopes of Nasdaq being lenient with its process and said there were “zero” delisting fears because, with the extension, Tilray has until April 2026 to regain compliance.<stembedurl>https://stocktwits.com/Finance88/message/609341203</stembedurl>Another user said the company is “vertically scaled to be dominant from flower to drinks to pharma,” pointing to its products being available on the multinational supermarket chain Whole Foods, which is owned by Amazon.com.<stembedurl>https://stocktwits.com/Heb1972/message/609362664</stembedurl>Several retail investors on Stocktwits hope Tilray does not resort to a reverse stock split.<stembedurl>https://stocktwits.com/Rs1015/message/609258289</stembedurl>In January, Tilray’s stock was dealt a blow after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tlry-stock-slides-after-q2-2025-results/chGWAd2RZD">reported</a> disappointing quarterly results and projected a $20 million revenue blow for 2025 from cutting back on certain alcohol beverage brands.Meanwhile, the company said Wednesday that the Massachusetts Superior Court dismissed a lawsuit filed by a shareholder against the company and its subsidiary Hexo.The plaintiff claimed Tilray failed to inform shareholders about Hexo’s corporate actions in late 2022 and its 2023 acquisition, allegedly causing financial losses. He sought nearly $8 million in damages.&nbsp;According to Koyfin data, short interest on Tilray has shot up from 12.7% at the start of the year to 17.3% as of the last week.The stock trades at a significant 180% discount to Wall Street’s average price target of $1.83. Out of 13 analysts covering it, nine rate it ‘hold’ and four ‘buy.’For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of a Canadian pharmaceutical and cannabis company, Tilray, is seen on a smartphone and a PC screen. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Tilray Retail Bulls See Nasdaq Compliance On The Horizon, Shareholder Lawsuit Victory Adds Cheer

The company has 180 calendar days to meet Nasdaq's minimum bid price rule. Its stock must close at or above $1.00 per share for at least 10 consecutive business days before Sept. 21.

Equity

The company has 180 calendar days to meet Nasdaq's minimum bid price rule. Its stock must close at or above $1.00 per share for at least 10 consecutive business days before Sept. 21.


Shares of cannabis retailer Curaleaf Holdings dropped nearly 10% on Monday after the company posted mixed fourth-quarter earnings.&nbsp;While Curaleaf reported a profit of $12.4 million, or $0.02 per share, compared with a $5 million loss from the same period last year, revenue declined to $331.1 million from $345.3 million.Chairman and CEO Boris Jordan highlighted the company's profitability metrics, noting that Curaleaf achieved an adjusted gross margin of 48% and an adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $76 million.&nbsp;He also pointed to the company's strengthened cash position, with $107 million in cash at year-end, and operating and free cash flow of $163 million and $70 million, respectively."Over the past two quarters, my primary objective has been to amplify our strengths, address key challenges, and stabilize the business," Jordan said."Having successfully achieved this, we are now forging ahead with our 'Return to our ROOTS' initiative—an ambitious strategy centered on driving organic growth, optimizing margins and cash flow, and reducing debt."Message volume for Curaleaf surged 366% on Stocktwits following the earnings release, with posts reflecting a divide between bullish and bearish sentiment.&nbsp;One trader emphasized Curaleaf's dominant position in the industry, its $1.34 billion annual sales, and improving cash flow, arguing that the company remains well-positioned despite foreign exchange headwinds affecting international sales.&nbsp;<stembedurl>https://stocktwits.com/angelfromsky/message/606622013</stembedurl>Others, however, focused on the revenue decline, with one trader calling it a "solid miss as usual" and another predicting that the stock would slip below $1.<stembedurl>https://stocktwits.com/symbol/CURLF/earnings</stembedurl>Curaleaf and its industry peers have been&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.marketwatch.com/story/trulieve-curaleaf-and-green-thumb-launch-hemp-based-thc-drinks-as-cannabis-reforms-stall-2f03d249">expanding</a> into THC-infused beverages as federal cannabis legalization efforts stall.&nbsp;Last week, the company announced a partnership with Total Wine &amp; More to distribute its Select Zero Proof line of hemp-derived THC seltzers.Curaleaf stock has lost over 28% this year.&nbsp;According to Koyfin data, it trades about 240% below the average price target of $4.02 from 10 analysts. Seven rate it a 'buy,' one assigns a 'strong buy,' and two have a 'hold' rating.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A Curaleaf medical cannabis dispensary in Forest Hills, Queens, NY. (Photo by: Lindsey Nicholson/UCG/Universal Images Group via Getty Images)

Curaleaf's Q4 Profit Swing Ignites Retail Chatter, But Shrinking Revenue Dampens The High

Chairman and CEO Boris Jordan pointed to the company's strengthened cash position, with $107 million in cash at year-end, and operating and free cash flow of $163 million and $70 million.

Shares of Tilray Brands tumbled over 12% on Thursday, hitting their lowest point since Dec. 20, as the cannabis and beer company reported disappointing fiscal second-quarter (Q2) results and projected a $20 million revenue blow for 2025.The company posted a Q2 net loss of $85.3 million, nearly doubling its year-ago loss of $46.2 million.&nbsp;Cannabis net revenue fell slightly to $66 million from $67 million in the prior year.&nbsp;While overall Q2 revenue rose 8.8% year-over-year to $211 million, it missed Wall Street’s estimate of $216.33 million.Tilray also launched “Project 420,” a $25 million initiative to streamline its beverage business.&nbsp;The plan involves cutting back on certain alcohol beverage brands,&nbsp;which will contribute to the $20 million anticipated revenue impact for fiscal 2025.&nbsp;The company cited prioritizing key products and discontinuing underperforming stock keeping units (SKUs) as reasons for the dip.&nbsp;For the six months ended Nov. 30, 2024, the company reported a $6.0 million reduction in net sales, driven by the prioritization of certain products in key markets.&nbsp;An additional $2.0 million decline resulted from the decision to discontinue specific SKUs due to market conditions, Tilray said.However,&nbsp;the firm expects the move to be offset by innovation in new beverage categories and brand extensions over the next 18 months.<figure class="image"><img style="aspect-ratio:1318/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/TLRY_sentiment_and_message_volume_Jan_10_premarket_d6cc8d488d.png" alt="TLRY sentiment and message volume Jan 10 premarket.png" width="1318" height="324"><figcaption>TLRY sentiment and message volume Jan 10 as of 11 am ET | source: Stocktwits</figcaption></figure>Despite the underwhelming financial performance, retail investors on Stocktwits remained surprisingly bullish.&nbsp;Many speculated on the possibility of a reverse stock split and expressed optimism about management’s potential for a turnaround.&nbsp;<stembedurl>https://stocktwits.com/PerCentInvestments/message/599550073</stembedurl><stembedurl>https://stocktwits.com/PerCentInvestments/message/599550073</stembedurl><stembedurl>https://stocktwits.com/Finer1m2/message/599547388</stembedurl><stembedurl>https://stocktwits.com/Big_Fish_76/message/599462909</stembedurl>There was also some solace in Tilray breaking even on an adjusted basis, outperforming analysts’ expectations of a $0.03 per share loss.<a href="https://stocktwits.com/symbol/TLRY">Tilray's stock</a> lost 34% in 2024.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tilray Stock Dips To 4-Week Low On $20M Revenue Blow Projection For 2025, But Retail’s Still Riding High

Tilray launched “Project 420,” a $25 million initiative to streamline its beverage business that involves cutting back on certain alcohol brands.

CNBS
Amplify Seymour Cannabis ETF

Feed

News

Sentiment

Fundamentals

Info

Latest CNBS News

CNBSAmplify Seymour Cannabis ETF